{"DataElement":{"publicId":"3397320","version":"3","preferredName":"Off Treatment Contribution Description  COG Code","preferredDefinition":"The contributing COG protocol defined explanation of the cause of Off-Treatment.","longName":"CbtRopt","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"3397319","version":"1","preferredName":"Off Treatment Contribution Description","preferredDefinition":"An explanation of the contributing cause of Off-Treatment; the phase of a protocol during which a patient does not receive treatment.","longName":"2184317v1.0:3397317v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2184317","version":"1","preferredName":"Off-Treatment","preferredDefinition":"Off-Treatment; the phase of a protocol during which a patient does not receive treatment.","longName":"Off-Treatment","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Off Treatment","conceptCode":"C25601","definition":"When a patient is not receiving therapy they are considered off treatment.  In clinical trials, a dosing schedule may require a patient to stop medication for a period of time, then resume, such as 28 days on and 7 days off.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1E5A-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3384623","version":"1","preferredName":"Contribution Description","preferredDefinition":"The part played by somebody or something in bringing about an end or result.:Description; a statement that represents something in words.","longName":"C61412:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Contribution","conceptCode":"C61412","definition":"The part played by somebody or something in bringing about an end or result.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B997EC81-7B42-A0EB-E040-BB89AD4377D2","latestVersionIndicator":"Yes","beginDate":"2012-02-22","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-22","modifiedBy":"ONEDATA","dateModified":"2012-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-92A2-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3397015","version":"3","preferredName":"Off Treatment COG Code","preferredDefinition":"A COG protocol defined explanation of the cause of Off-Treatment.","longName":"Ropt","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"40","valueDescription":"Adverse Events requiring removal from protocol therapy","ValueMeaning":{"publicId":"3397024","version":"1","preferredName":"Adverse Events requiring removal from protocol therapy","longName":"3397024","preferredDefinition":"Adverse Events requiring removal from protocol therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-91B8-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F05A-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"33","valueDescription":"Clinical or radiographic evidence of progressive disease","ValueMeaning":{"publicId":"3397025","version":"1","preferredName":"Clinical or radiographic evidence of progressive disease","longName":"3397025","preferredDefinition":"Clinical or radiographic evidence of progressive disease","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-91DB-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F064-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"3","valueDescription":"Completion of planned therapy","ValueMeaning":{"publicId":"3397022","version":"1","preferredName":"Completion of planned therapy","longName":"3397022","preferredDefinition":"Completion of planned therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-9168-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"KUMMEROA","dateModified":"2022-10-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F06E-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"158","valueDescription":"Death","ValueMeaning":{"publicId":"3141242","version":"1","preferredName":"Death","longName":"3141242","preferredDefinition":"The cessation of life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90DEC4CC-5E17-3212-E040-BB89AD436EBB","latestVersionIndicator":"Yes","beginDate":"2010-09-22","endDate":null,"createdBy":"LUY","dateCreated":"2010-09-22","modifiedBy":"GDEEN","dateModified":"2023-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F078-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"257","valueDescription":"Enrollment onto another COG therapeutic (anti-cancer) study","ValueMeaning":{"publicId":"3397016","version":"1","preferredName":"Enrollment onto another COG therapeutic (anti-cancer) study","longName":"3397016","preferredDefinition":"Enrollment onto another COG therapeutic (anti-cancer) study","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-9077-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F082-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"5","valueDescription":"Lost to follow-up","ValueMeaning":{"publicId":"2569172","version":"1","preferredName":"Lost to follow-up","longName":"2569172","preferredDefinition":"The loss or lack of continuation of subject participation after a study has officially closed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lost To Follow-Up","conceptCode":"C48227","definition":"The loss or lack of continuation of subject participation after a study has officially closed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DB41-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-13","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-04-13","modifiedBy":"COOPERM","dateModified":"2015-01-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F08C-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"36","valueDescription":"Non-compliance that in the opinion of the investigator does not allow for ongoing participation","ValueMeaning":{"publicId":"3397023","version":"1","preferredName":"Non-compliance that in the opinion of the investigator does not allow for ongoing participation","longName":"3397023","preferredDefinition":"Non-compliance that in the opinion of the investigator does not allow for ongoing participation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-918B-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F096-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"162","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0A0-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"38","valueDescription":"Physician determines it is not in the patient's best interest","ValueMeaning":{"publicId":"3412738","version":"1","preferredName":"Physician determines it is not in the patient's best interest","longName":"3412738","preferredDefinition":"Physician determines it is not in the patient's best interest","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB1063B9-E9B1-5F5A-E040-BB89AD4367BE","latestVersionIndicator":"Yes","beginDate":"2012-03-12","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0AA-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"121","valueDescription":"Pregnancy","ValueMeaning":{"publicId":"2570603","version":"1","preferredName":"Pregnancy","longName":"2570603","preferredDefinition":"Pregnancy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E0D8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0B4-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"35","valueDescription":"Refusal of further protocol therapy by patient/parent/guardian","ValueMeaning":{"publicId":"3389978","version":"1","preferredName":"Refusal of further protocol therapy by patient/parent/guardian","longName":"3389978","preferredDefinition":"Refusal of further protocol therapy by patient/parent/guardian","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA09DDE8-2C40-B133-E040-BB89AD431578","latestVersionIndicator":"Yes","beginDate":"2012-02-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2012-02-28","modifiedBy":"PWEST","dateModified":"2013-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0BE-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"144","valueDescription":"Repeated eligibility laboratory studies are outside the parameters required for eligibility prior to the start of protocol therapy","ValueMeaning":{"publicId":"3397020","version":"1","preferredName":"Repeated eligibility laboratory studies are outside the parameters required for eligibility prior to the start of protocol therapy","longName":"3397020","preferredDefinition":"Repeated eligibility laboratory studies are outside the parameters required for eligibility prior to the start of protocol therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-9122-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0C8-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"295","valueDescription":"Study is terminated by Sponsor","ValueMeaning":{"publicId":"3397019","version":"1","preferredName":"Study is terminated by Sponsor","longName":"3397019","preferredDefinition":"Study is terminated by Sponsor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-90FF-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"CAMPBELB","dateModified":"2013-09-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0D2-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"200","valueDescription":"Thirty days after the last dose of the investigational agent","ValueMeaning":{"publicId":"3397018","version":"1","preferredName":"Thirty days after the last dose of the investigational agent","longName":"3397018","preferredDefinition":"Thirty days after the last dose of the investigational agent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-90D1-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0DC-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"4","valueDescription":"Withdrawal of consent for any further required observations or data submission","ValueMeaning":{"publicId":"3397017","version":"1","preferredName":"Withdrawal of consent for any further required observations or data submission","longName":"3397017","preferredDefinition":"Withdrawal of consent for any further required observations or data submission","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA34F3E4-909A-41C1-E040-BB89AD433B93","latestVersionIndicator":"Yes","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0E6-D6E3-E040-BB89AD430833","beginDate":"2012-03-01","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"901","valueDescription":"Patients with SD or any response off protocol therapy after the fourth cycle or after the response evaluation following any subsequent cycle of therapy","ValueMeaning":{"publicId":"3536755","version":"1","preferredName":"Patients with SD or any response off protocol therapy after the fourth cycle or after the response evaluation following any subsequent cycle of therapy","longName":"3536755","preferredDefinition":"Patients with SD or any response off protocol therapy after the fourth cycle or after the response evaluation following any subsequent cycle of therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6256624-E2F5-177C-E040-BB89AD437EBF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0F0-D6E3-E040-BB89AD430833","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"900","valueDescription":"Patients with CR after two cycles off protocol therapy for stem cell transplantation","ValueMeaning":{"publicId":"3536756","version":"1","preferredName":"Patients with CR after two cycles off protocol therapy for stem cell transplantation","longName":"3536756","preferredDefinition":"Patients with CR after two cycles off protocol therapy for stem cell transplantation","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6256624-E318-177C-E040-BB89AD437EBF","latestVersionIndicator":"Yes","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D3F9C26D-F0FA-D6E3-E040-BB89AD430833","beginDate":"2012-07-31","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"ONEDATA","dateModified":"2013-01-23","deletedIndicator":"No"},{"value":"902","valueDescription":"Delay in treatment resulting in drug interruption of study drug for indicated number of days","ValueMeaning":{"publicId":"3729651","version":"1","preferredName":"Delay in treatment resulting in drug interruption of study drug for indicated number of days","longName":"3729651","preferredDefinition":"Delay in treatment resulting in drug interruption of study drug for indicated number of days","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB0FA9D2-B49C-7457-E040-BB89AD435F8E","latestVersionIndicator":"Yes","beginDate":"2013-04-23","endDate":null,"createdBy":"MATTHEWK","dateCreated":"2013-04-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0FA9D2-B4B5-7457-E040-BB89AD435F8E","beginDate":"2013-04-23","endDate":null,"createdBy":"MATTHEWK","dateCreated":"2013-04-23","modifiedBy":"ONEDATA","dateModified":"2013-04-23","deletedIndicator":"No"},{"value":"303","valueDescription":"Fifth anniversary of study entry","ValueMeaning":{"publicId":"3727256","version":"1","preferredName":"Fifth anniversary of study entry","longName":"3727256","preferredDefinition":"Fifth anniversary of study entry","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA81DC97-87FC-5065-E040-BB89AD4338AB","latestVersionIndicator":"Yes","beginDate":"2013-04-16","endDate":null,"createdBy":"MATTHEWK","dateCreated":"2013-04-16","modifiedBy":"DWARZEL","dateModified":"2018-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA81DC97-8815-5065-E040-BB89AD4338AB","beginDate":"2013-04-16","endDate":null,"createdBy":"MATTHEWK","dateCreated":"2013-04-16","modifiedBy":"ONEDATA","dateModified":"2013-04-16","deletedIndicator":"No"},{"value":"903","valueDescription":"45 days after the last dose of the investigational agent","ValueMeaning":{"publicId":"4030211","version":"1","preferredName":"45 days after the last dose of the investigational agent","longName":"4030211","preferredDefinition":"45 days after the last dose of the investigational agent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EE504ABB-ED33-D1BA-E040-BB89AD433E8C","latestVersionIndicator":"Yes","beginDate":"2013-12-24","endDate":null,"createdBy":"MATTHEWK","dateCreated":"2013-12-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EE504ABB-ED4C-D1BA-E040-BB89AD433E8C","beginDate":"2013-12-24","endDate":null,"createdBy":"MATTHEWK","dateCreated":"2013-12-24","modifiedBy":"ONEDATA","dateModified":"2013-12-24","deletedIndicator":"No"},{"value":"8","valueDescription":"Development of a second malignant neoplasm","ValueMeaning":{"publicId":"4690231","version":"1","preferredName":"Development of a second malignant neoplasm","longName":"4690231","preferredDefinition":"Development of a second malignant neoplasm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0DCFEA70-0B1B-6D7F-E050-BB89AD434E9E","latestVersionIndicator":"Yes","beginDate":"2015-01-29","endDate":null,"createdBy":"WANGC","dateCreated":"2015-01-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0DCFEA70-0B34-6D7F-E050-BB89AD434E9E","beginDate":"2015-01-29","endDate":null,"createdBy":"WANGC","dateCreated":"2015-01-29","modifiedBy":"ONEDATA","dateModified":"2015-01-29","deletedIndicator":"No"},{"value":"907","valueDescription":"Clinical or radiographic evidence of progressive disease greater than 12 weeks after start of protocol therapy","ValueMeaning":{"publicId":"4656711","version":"1","preferredName":"Clinical or radiographic evidence of progressive disease greater than 12 weeks after start of protocol therapy","longName":"4656711","preferredDefinition":"Clinical or radiographic evidence of progressive disease greater than 12 weeks after start of protocol therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C16C781-92D0-707E-E050-BB89AD432763","latestVersionIndicator":"Yes","beginDate":"2015-01-07","endDate":null,"createdBy":"ZORINR","dateCreated":"2015-01-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C16C781-92E9-707E-E050-BB89AD432763","beginDate":"2015-01-07","endDate":null,"createdBy":"ZORINR","dateCreated":"2015-01-07","modifiedBy":"ONEDATA","dateModified":"2015-01-07","deletedIndicator":"No"},{"value":"906","valueDescription":"Clinical or radiographic evidence of progressive disease of greater than 40% increase from baseline target lesions selected according to RECIST criteria","ValueMeaning":{"publicId":"4656712","version":"1","preferredName":"Clinical or radiographic evidence of progressive disease of greater than 40% increase from baseline target lesions selected according to RECIST criteria","longName":"4656712","preferredDefinition":"Clinical or radiographic evidence of progressive disease of greater than 40% increase from baseline target lesions selected according to RECIST criteria","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C16C781-92F3-707E-E050-BB89AD432763","latestVersionIndicator":"Yes","beginDate":"2015-01-07","endDate":null,"createdBy":"ZORINR","dateCreated":"2015-01-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C16C781-930C-707E-E050-BB89AD432763","beginDate":"2015-01-07","endDate":null,"createdBy":"ZORINR","dateCreated":"2015-01-07","modifiedBy":"ONEDATA","dateModified":"2015-01-07","deletedIndicator":"No"},{"value":"905","valueDescription":"100 days after the last dose of the investigational agent","ValueMeaning":{"publicId":"4656713","version":"1","preferredName":"100 days after the last dose of the investigational agent","longName":"4656713","preferredDefinition":"100 days after the last dose of the investigational agent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0C16C781-9316-707E-E050-BB89AD432763","latestVersionIndicator":"Yes","beginDate":"2015-01-07","endDate":null,"createdBy":"ZORINR","dateCreated":"2015-01-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0C16C781-932F-707E-E050-BB89AD432763","beginDate":"2015-01-07","endDate":null,"createdBy":"ZORINR","dateCreated":"2015-01-07","modifiedBy":"ONEDATA","dateModified":"2015-01-07","deletedIndicator":"No"},{"value":"908","valueDescription":"Bone marrow findings consistent with myelodysplastic syndrome (MDS)/acute myeloid leukaemia (AML)","ValueMeaning":{"publicId":"5913588","version":"1","preferredName":"Bone marrow findings consistent with myelodysplastic syndrome (MDS)/acute myeloid leukaemia (AML)","longName":"5913588","preferredDefinition":"Bone marrow findings consistent with myelodysplastic syndrome (MDS)/acute myeloid leukaemia (AML)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"548D2365-324B-0C8E-E053-F662850A2747","latestVersionIndicator":"Yes","beginDate":"2017-07-17","endDate":null,"createdBy":"MARTINEZW","dateCreated":"2017-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"548D2365-3264-0C8E-E053-F662850A2747","beginDate":"2017-07-17","endDate":null,"createdBy":"MARTINEZW","dateCreated":"2017-07-17","modifiedBy":"ONEDATA","dateModified":"2017-07-17","deletedIndicator":"No"},{"value":"103","valueDescription":"Patient did not receive protocol treatment after study enrollment.","ValueMeaning":{"publicId":"6028509","version":"1","preferredName":"Patient did not receive protocol treatment after study enrollment.","longName":"6028509","preferredDefinition":"Patient did not receive protocol treatment after study enrollment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5E09C1CD-2DF3-6E8A-E053-F662850A4A68","latestVersionIndicator":"Yes","beginDate":"2017-11-15","endDate":null,"createdBy":"ARAGONP","dateCreated":"2017-11-15","modifiedBy":"DWARZEL","dateModified":"2018-06-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5E09C1CD-2E0C-6E8A-E053-F662850A4A68","beginDate":"2017-11-15","endDate":null,"createdBy":"ARAGONP","dateCreated":"2017-11-15","modifiedBy":"ONEDATA","dateModified":"2017-11-15","deletedIndicator":"No"},{"value":"117","valueDescription":"Treatment failure","ValueMeaning":{"publicId":"5067151","version":"1","preferredName":"Treatment failure","longName":"5067151","preferredDefinition":"Treatment failure","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25F4E6D2-E884-841F-E050-BB89AD430F79","latestVersionIndicator":"Yes","beginDate":"2015-12-02","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76B51C35-8F95-312A-E053-F662850A0294","beginDate":"2018-09-25","endDate":null,"createdBy":"ARAGONP","dateCreated":"2018-09-25","modifiedBy":"ONEDATA","dateModified":"2018-09-25","deletedIndicator":"No"},{"value":"916","valueDescription":"Histologic diagnosis of recurrent malignancy not confirmed within one month of enrollment.","ValueMeaning":{"publicId":"7239850","version":"1","preferredName":"Histologic diagnosis of recurrent malignancy not confirmed within one month of enrollment.","longName":"7239850","preferredDefinition":"Histologic diagnosis of recurrent malignancy not confirmed within one month of enrollment.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2A7A965-0C3B-68E9-E053-F662850AC940","latestVersionIndicator":"Yes","beginDate":"2020-04-06","endDate":null,"createdBy":"LEEBUMJ","dateCreated":"2020-04-06","modifiedBy":"ONEDATA","dateModified":"2020-04-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2A7A965-0C54-68E9-E053-F662850AC940","beginDate":"2020-04-06","endDate":null,"createdBy":"LEEBUMJ","dateCreated":"2020-04-06","modifiedBy":"ONEDATA","dateModified":"2020-04-06","deletedIndicator":"No"},{"value":"909","valueDescription":"Completion of 26 cycles of therapy","ValueMeaning":{"publicId":"6720232","version":"1","preferredName":"Completion of 26 cycles of therapy","longName":"6720232","preferredDefinition":"Completion of 26 cycles of therapy","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"874A60EB-B699-1F90-E053-F662850A4751","latestVersionIndicator":"Yes","beginDate":"2019-04-24","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"874A60EB-B6B2-1F90-E053-F662850A4751","beginDate":"2019-04-24","endDate":null,"createdBy":"SHOARYAS","dateCreated":"2019-04-24","modifiedBy":"ONEDATA","dateModified":"2019-04-24","deletedIndicator":"No"},{"value":"159","valueDescription":"Clinical Evidence Progressive Disease","ValueMeaning":{"publicId":"7097146","version":"1","preferredName":"Clinical Evidence Progressive Disease","longName":"7097146","preferredDefinition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.: Knowledge on which to base belief.: A disease process that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Evidence","conceptCode":"C43583","definition":"Knowledge on which to base belief.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A000BEF-9930-3A73-E053-F662850ABCA2","latestVersionIndicator":"Yes","beginDate":"2019-12-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2019-12-18","modifiedBy":"ONEDATA","dateModified":"2019-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A005165-15FD-3E52-E053-F662850AB4BD","beginDate":"2019-12-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2019-12-18","modifiedBy":"ONEDATA","dateModified":"2019-12-18","deletedIndicator":"No"},{"value":"914","valueDescription":"Completion of 6 cycles of therapy.","ValueMeaning":{"publicId":"7113598","version":"1","preferredName":"Completion of 6 cycles of therapy.","longName":"7113598","preferredDefinition":"Completion of 6 cycles of therapy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A9FC1FE-F92A-2DE9-E053-F662850A34AB","latestVersionIndicator":"Yes","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9FC1FE-F943-2DE9-E053-F662850A34AB","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","deletedIndicator":"No"},{"value":"913","valueDescription":"An infusion stop or delay of more than 2 weeks due to AE or more than 2 discontinuations per cycle due to AE (does not apply for prolongation of the scheduled treatment free period of a cycle).","ValueMeaning":{"publicId":"7113599","version":"1","preferredName":"An infusion stop or delay of more than 2 weeks due to AE or more than 2 discontinuations per cycle due to AE (does not apply for prolongation of the scheduled treatment free period of a cycle).","longName":"7113599","preferredDefinition":"An infusion stop or delay of more than 2 weeks due to AE or more than 2 discontinuations per cycle due to AE (does not apply for prolongation of the scheduled treatment free period of a cycle).","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A9FC1FE-F94D-2DE9-E053-F662850A34AB","latestVersionIndicator":"Yes","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9FC1FE-F966-2DE9-E053-F662850A34AB","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","deletedIndicator":"No"},{"value":"912","valueDescription":"Development of a DLT following 1 dose reduction.","ValueMeaning":{"publicId":"7113600","version":"1","preferredName":"Development of a DLT following 1 dose reduction.","longName":"7113600","preferredDefinition":"Development of a DLT following 1 dose reduction.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A9FC1FE-F970-2DE9-E053-F662850A34AB","latestVersionIndicator":"Yes","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9FC1FE-F989-2DE9-E053-F662850A34AB","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","deletedIndicator":"No"},{"value":"910","valueDescription":"Have not achieved at least a PR following 2 successive treatment cycles.","ValueMeaning":{"publicId":"7113601","version":"1","preferredName":"Have not achieved at least a PR following 2 successive treatment cycles.","longName":"7113601","preferredDefinition":"Have not achieved at least a PR following 2 successive treatment cycles.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A9FC1FE-F993-2DE9-E053-F662850A34AB","latestVersionIndicator":"Yes","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A9FC1FE-F9AC-2DE9-E053-F662850A34AB","beginDate":"2019-12-26","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-26","modifiedBy":"ONEDATA","dateModified":"2019-12-26","deletedIndicator":"No"},{"value":"915","valueDescription":"The patient does not receive protocol treatment after study enrollment","ValueMeaning":{"publicId":"6343797","version":"1","preferredName":"The patient does not receive protocol treatment after study enrollment","longName":"6343797","preferredDefinition":"The patient does not receive protocol treatment after study enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FB8AEF6-6EB7-0892-E053-F662850ABECA","latestVersionIndicator":"Yes","beginDate":"2018-06-28","endDate":null,"createdBy":"SARMIENTOL","dateCreated":"2018-06-28","modifiedBy":"ONEDATA","dateModified":"2018-06-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9BA637AF-EF70-1540-E053-F662850A53EE","beginDate":"2020-01-09","endDate":null,"createdBy":"RODELAA","dateCreated":"2020-01-09","modifiedBy":"ONEDATA","dateModified":"2020-01-09","deletedIndicator":"No"},{"value":"104","valueDescription":"The patient does not recieve protocol treatment after study enrollment","ValueMeaning":{"publicId":"7092906","version":"1","preferredName":"The patient does not recieve protocol treatment after study enrollment","longName":"7092906","preferredDefinition":"The patient does not recieve protocol treatment after study enrollment","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"99D6ADE6-0B53-743B-E053-F662850A05E5","latestVersionIndicator":"Yes","beginDate":"2019-12-16","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-16","modifiedBy":"ONEDATA","dateModified":"2019-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"99D6ADE6-0B6C-743B-E053-F662850A05E5","beginDate":"2019-12-16","endDate":null,"createdBy":"RODELAA","dateCreated":"2019-12-16","modifiedBy":"ONEDATA","dateModified":"2019-12-16","deletedIndicator":"No"},{"value":"202","valueDescription":"Second Anniversary Clinical Trial Enrollment Date","ValueMeaning":{"publicId":"7097167","version":"1","preferredName":"Second Anniversary Clinical Trial Enrollment Date","longName":"7097167","preferredDefinition":"A unit of time, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour.: No Value Exists: A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.: The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.: The particular day, month and year an event has happened or will happen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C42535","definition":"A unit of time, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Anniversary","conceptCode":"C0003097","definition":"No Value Exists","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Trial","conceptCode":"C71104","definition":"A research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Enrollment","conceptCode":"C37948","definition":"The act of registration, entering in a list, catalog, group, study; also, the number of subjects enrolled.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Date","conceptCode":"C25164","definition":"The particular day, month and year an event has happened or will happen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A007F7E-3172-4172-E053-F662850ABDE1","latestVersionIndicator":"Yes","beginDate":"2019-12-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2019-12-18","modifiedBy":"MAESKEB","dateModified":"2019-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A007F7E-318B-4172-E053-F662850ABDE1","beginDate":"2019-12-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2019-12-18","modifiedBy":"ONEDATA","dateModified":"2019-12-18","deletedIndicator":"No"},{"value":"201","valueDescription":"One Year Post Last Dose Investigational Agent","ValueMeaning":{"publicId":"7097168","version":"1","preferredName":"One Year Post Last Dose Investigational Agent","longName":"7097168","preferredDefinition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.: A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.: Happening at a time subsequent to a reference time; later in time or order.: Coming after all others in time or space or degree or being the only one remaining.: A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.: In the process of being studied; experimental.: An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Year","conceptCode":"C29848","definition":"A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Last","conceptCode":"C25551","definition":"Coming after all others in time or space or degree or being the only one remaining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Investigational","conceptCode":"C28041","definition":"In the process of being studied; experimental.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A007F7E-319D-4172-E053-F662850ABDE1","latestVersionIndicator":"Yes","beginDate":"2019-12-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2019-12-18","modifiedBy":"ONEDATA","dateModified":"2019-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9A007F7E-31B8-4172-E053-F662850ABDE1","beginDate":"2019-12-18","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2019-12-18","modifiedBy":"ONEDATA","dateModified":"2019-12-18","deletedIndicator":"No"},{"value":"203","valueDescription":"Failure to adequately recover from surgery within 6 weeks after surgery (patients in Part C)","ValueMeaning":{"publicId":"7594508","version":"1","preferredName":"Failure to adequately recover from surgery within 6 weeks after surgery (patients in Part C)","longName":"7594508","preferredDefinition":"Failure to adequately recover from surgery within 6 weeks after surgery (patients in Part C)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BD4BA692-8444-40E1-E053-4EBD850A34A1","latestVersionIndicator":"Yes","beginDate":"2021-03-11","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-03-11","modifiedBy":"ONEDATA","dateModified":"2021-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD4BA692-845D-40E1-E053-4EBD850A34A1","beginDate":"2021-03-11","endDate":null,"createdBy":"CARPIOJ","dateCreated":"2021-03-11","modifiedBy":"ONEDATA","dateModified":"2021-03-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008554","version":"1","preferredName":"Treatment/Off-treatment Reasons","preferredDefinition":"justification for or explanation of the administration or cessation of therapy.","longName":"TX_OTX_RSNS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2C9BE32-8BDB-649C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3450431","version":"1","preferredName":"Off Treatment Code","preferredDefinition":"Off-Treatment; the phase of a protocol during which a patient does not receive treatment.:A system of numbered categories for representation of data.","longName":"C25601:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Off Treatment","conceptCode":"C25601","definition":"When a patient is not receiving therapy they are considered off treatment.  In clinical trials, a dosing schedule may require a patient to stop medication for a period of time, then resume, such as 28 days on and 7 days off.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF38F5D0-B850-041D-E040-BB89AD431251","latestVersionIndicator":"Yes","beginDate":"2012-05-04","endDate":null,"createdBy":"BEELEST","dateCreated":"2012-05-04","modifiedBy":"ONEDATA","dateModified":"2012-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3F9C26D-F044-D6E3-E040-BB89AD430833","latestVersionIndicator":"Yes","beginDate":"2013-01-23","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"CARPIOJ","dateModified":"2021-03-11","changeDescription":"Short Name change to readable value. Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]}],"AlternateNames":[{"name":"CbtRopt","type":"USED_BY","context":"CTEP"}],"ReferenceDocuments":[{"name":"Contributing reason patient i","type":"Preferred Question Text","description":"Contributing reason patient is off protocol therapy","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Contributing reason(s) patient is off protocol therapy or off study:","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_2","type":"Alternate Question Text","description":"Primary reason patient is off study","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3FA6A93-9A66-64AF-E040-BB89AD4342AF","latestVersionIndicator":"Yes","beginDate":"2013-01-23","endDate":null,"createdBy":"BEELEST","dateCreated":"2013-01-23","modifiedBy":"BEELEST","dateModified":"2014-02-20","changeDescription":"Value Domain updated for codes in place of text reasons for permissible values; Update V3 short name readable value. Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}